Assignee
IMCYSE SA
BE10 patents
Top patents by PatentIndex Score
US11407795B2Aug 9, 2022
Peptides and methods for the treatment of diabetes
IMCYSE SA4 citations82
US10808016B2Oct 20, 2020
Peptides and methods for the treatment of diabetes
IMCYSE SA6 citations82
US11718650B2Aug 8, 2023
Immunogenic peptides and their use in immune disorders
IMCYSE SA1 citations72
US11760782B2Sep 19, 2023
Peptides and methods for the treatment of diabetes
IMCYSE SA2 citations71
US11226332B2Jan 18, 2022
Method for the detection, preparation and depletion of CD4+ t lymphocytes
IMCYSE SA3 citations71
US10729791B2Aug 4, 2020
Animal models for evaluating pharmaceutical compounds
IMCYSE SA3 citations71
US11485768B2Nov 1, 2022
Immunogenic CD1d binding peptides
IMCYSE SA3 citations70
US12583891B2Mar 24, 2026
Peptides and methods for the treatment of diabetes
IMCYSE SA0 citations60
US12023384B2Jul 2, 2024
Immunogenic peptides comprising an MHC class II T cell epitope and a redox motif
IMCYSE SA1 citations60
US11787849B2Oct 17, 2023
Methods and compounds for eliminating immune responses to therapeutic agents
IMCYSE SA1 citations60